Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent hypertension trials: implications and controversies.

Bryan Williams1

  • 1Department of Cardiovascular Sciences, University of Leicester School of Medicine, Leicester, United Kingdom. bw17@le.ac.uk

Journal of the American College of Cardiology
|March 16, 2005
PubMed
Summary

Hypertension treatment lowers blood pressure, reducing cardiovascular risk. Adding statins offers additional benefits beyond blood pressure control for comprehensive cardiovascular disease prevention.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Generating evidence using electronic alerts during routine care: a fully automated randomized controlled trial of oral fluid restriction in acute heart failure (THIRST alert trial).

European heart journal. Digital health·2026
Same author

Cardiovascular Grand Challenge: a new funding initiative by the British Heart Foundation.

European heart journal·2026
Same author

Chemical adherence testing-guided intervention versus standard of care in patients with hypertension who are non-adherent to antihypertensive treatment in the UK (OUTREACH): a multicentre, randomised controlled trial.

The Lancet. Primary care·2026
Same author

Assessment of human immunity to A/H3N2 influenza subclade K during 2025 emergence.

EBioMedicine·2026
Same author

Improving the diagnostic performance of troponin assays for acute myocardial infarction in renal impairment.

Heart (British Cardiac Society)·2026
Same author

Prospective use of genomics in the evaluation of sudden cardiac death: results from a national health service population pathway.

EBioMedicine·2026

Area of Science:

  • Cardiology
  • Pharmacology
  • Epidemiology

Background:

  • Clinical trials confirm the benefits of pharmacologic hypertension treatment.
  • Debate exists on whether specific drug classes offer cardiovascular benefits beyond blood pressure reduction.
  • Large-scale studies and meta-analyses inform the discussion on hypertension management.

Purpose of the Study:

  • To evaluate the benefits of specific antihypertensive drug classes for cardiovascular disease prevention.
  • To interpret the significance of intermediate cardiovascular end points in relation to long-term outcomes.
  • To discuss the evolving understanding of hypertension treatment goals beyond single risk factor intervention.

Main Methods:

  • Review of extensive clinical trial data on hypertension pharmacotherapy.

Related Experiment Videos

  • Analysis of updated large-scale epidemiologic studies.
  • Meta-analysis of clinical trial data to assess cardiovascular outcomes.

    • Main Results:

    • The primary driver of clinical benefit is the magnitude and speed of blood pressure reduction.
    • Drug-specific differences in intermediate cardiovascular end points are noted but require interpretation for long-term outcomes.
    • Current evidence emphasizes blood pressure reduction as the main benefit, with ongoing debate on drug-specific advantages.

    Conclusions:

    • Blood pressure lowering is crucial for cardiovascular disease prevention.
    • The concept of targeting overall cardiovascular disease risk is gaining prominence over single risk factor intervention.
    • Adding statins is highlighted as an effective strategy to "go beyond blood pressure" for enhanced cardiovascular protection.